Inari Medical Inc Receivables Turnover Ratio (NARI), from the third quarter 2024 to the third quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Inari Medical Inc   (NASDAQ: NARI)
 

Inari Medical Inc Accounts Receivables Turnover Ratio from the third quarter 2024 to the third quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Accounts Receivable turnover ratio remained unchanged during the third quarter 2024, compared to the previous quarter at 7.27 pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Average collection period, for Inari Medical Inc 's accounts receivable remained unchanged at 50 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 228 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 1780 to 1960.

What is Receivable Turnover Ratio?
What is Inari Medical Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NARI Receivables Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Receivable Change 21.28 % 29.31 % 41.1 % 19.63 % 28.74 %
Y / Y Revenue Change 21.17 % 21.7 % 22.5 % 22.95 % 30.86 %
Receivable Turnover Ratio (TTM) 7.27 7.27 7.39 7.64 7.59
NARI's Total Ranking # 1960 # 1780 # 980 # 919 # 1201
Accounts Receivable average collection period days 50 50 49 48 48
Seq. Receivable Change 3.4 % 3.83 % 12.13 % 0.75 % 10.24 %
Seq. Revenue Change 5.33 % 1.78 % 7.39 % 5.25 % 5.78 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 82
Healthcare Sector # 229
Overall Market # 1960

Receivable Turnover Ratio Statistics
High Average Low
7.77 7.44 6.6
(Mar 31 2022)   (Jun 30 2020)





NARI Company Profile • Back to NARI Efficiency Comparisons • Compare NARI Receivables Turnover Ratio to its Competitors

Financial Statements
Inari Medical Inc 's Accounts Receivable $ 84 Millions Visit NARI's Balance sheet
Inari Medical Inc 's Sales TTM $ 572 Millions Visit NARI's Income Statement
Sources of NARI's Revenues Visit NARI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NARI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NARI's Growth Rates NARI's Roa NARI's Inventory Turnover Ratio NARI's Dividend Comparisons
NARI's Profitability Ratios NARI's Roi NARI's Asset Turnover Ratio NARI's Dividend Growth
NARI's Valuation Ratios NARI's Roe NARI's Financial Strength Ratios NARI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Receivable at quarter ending Sep 30 2024
Kiniksa Pharmaceuticals International Plc  18.60 $ 384.098  Millions$ 20.650  Millions
Pulmatrix Inc   18.56 $ 10.005  Millions$ 0.539  Millions
Milestone Scientific Inc   18.54 $ 8.862  Millions$ 0.478  Millions
Hookipa Pharma inc   17.97 $ 49.999  Millions$ 2.782  Millions
Macrogenics Inc   17.38 $ 141.329  Millions$ 8.132  Millions
Zomedica Corp   17.34 $ 25.965  Millions$ 1.497  Millions
Talkspace Inc   16.98 $ 179.853  Millions$ 10.591  Millions
Medinotec Inc   16.59 $ 7.309  Millions$ 0.441  Millions
Scorpius Holdings inc   16.51 $ 10.044  Millions$ 0.608  Millions
Sangamo Therapeutics Inc   16.48 $ 52.291  Millions$ 3.173  Millions
Stablecoin Development Corporation  16.33 $ 11.199  Millions$ 0.686  Millions
Nexalin Technology Inc   16.24 $ 0.162  Millions$ 0.010  Millions
Inmed Pharmaceuticals Inc  16.11 $ 4.284  Millions$ 0.266  Millions
Precipio inc   16.07 $ 17.411  Millions$ 1.084  Millions
Fortress Biotech Inc   15.68 $ 62.501  Millions$ 3.986  Millions
Icu Medical Inc  14.80 $ 2,340.754  Millions$ 158.125  Millions
Biofrontera Inc   14.40 $ 61.432  Millions$ 4.265  Millions
Bgm Group Ltd  14.36 $ 24.115  Millions$ 1.679  Millions
Valion Bio Inc   14.02 $ 0.957  Millions$ 0.068  Millions
Mannkind Corporation  14.00 $ 267.200  Millions$ 19.086  Millions
Ispecimen inc   13.70 $ 10.391  Millions$ 0.758  Millions
Qhslab Inc   13.69 $ 1.821  Millions$ 0.133  Millions
Lftd Partners Inc   13.08 $ 42.366  Millions$ 3.239  Millions
Escalon Medical Corp   13.07 $ 11.818  Millions$ 0.904  Millions
Patterson Companies Inc   13.07 $ 6,555.862  Millions$ 501.549  Millions
Nrc Health  12.92 $ 144.154  Millions$ 11.155  Millions
Chemed Corporation  12.84 $ 2,377.206  Millions$ 185.072  Millions
Vaxart Inc   12.79 $ 16.760  Millions$ 1.311  Millions
Vsee Health Inc   12.73 $ 8.115  Millions$ 0.637  Millions
International Stem Cell Corporation  12.65 $ 8.528  Millions$ 0.674  Millions

Date modified: 2026-10-07T00:41:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.